Semnur Pharmaceuticals, Inc. Investments, Fair Value Disclosure
Semnur Pharmaceuticals, Inc. (SMNR) had Investments, Fair Value Disclosure of $88.14 million as of 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Notes
us-gaap:InvestmentsFairValueDisclosure · last filed 2023-08-15
- 2023-06-30: Investments, Fair Value Disclosure $88.14M.
- 2022-12-31: Investments, Fair Value Disclosure $85.37M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2023-06-30 | $88.14M 10-Q · filed 2023-08-15 |
| 2022-12-31 | $85.37M 10-Q · filed 2023-08-15 |